Slideshow

Diabetes News Roundup: July 2018

Author(s):

Mark L. Fuerst

Highlights include how cost-effective insulin reduces hospital visits; prevalence of restrictive lung disease in T2DM patients; and the wonders of self-monitoring for cost of care.

Related Videos
Evaluating the Medtronic 780G System in Type 2 Diabetes | Image Credit: HCPLive
Understanding Omnipod 5 AID and SECURE-T2D | Image Credit: HCPLive
Pranav Garimella, MBBS, MPH | Credit: GlobalNewsWire
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Related Content
FDA Announces End to Shortage of Semaglutide Products (Ozempic, Wegovy) | Image Credit: US Food and Drug Administration
February 21st 2025

FDA Announces End to Shortage of Semaglutide Products (Ozempic, Wegovy)

Connor Iapoce
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
February 15th 2025

Diabetes Dialogue: Omnipod 5 and Medtronic 780G for Type 2 Diabetes

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
CELZ-201 Cuts Insulin Dependency at 1 Year in Patients with Type 2 Diabetes | Image Credit: LinkedIn
February 11th 2025

CELZ-201 Cuts Insulin Dependency at 1 Year in Patients with Type 2 Diabetes

Connor Iapoce
Medical Ethics Unpacked: GLP-1 Allocation
February 5th 2025

Medical Ethics Unpacked: GLP-1 Allocation and Challenges of Equitable Access

Steve Levine, MD Dominic Sisti, PhD
Novo Nordisk | Credit: Novo Nordisk
February 5th 2025

Monlunabant Misses Primary Endpoint in Phase 2 Diabetic Kidney Disease Trial

Abigail Brooks, MA
Kasia Lipska, MD, MHS, associate professor of medicine
February 4th 2025

Investigating the Link Between Type 2 Diabetes and Infection

Serena Crawford
© 2025 MJH Life Sciences

All rights reserved.